{"nctId":"NCT02101359","briefTitle":"Efficacy and Safety Assessment of Intracameral Injection of T2380 in Cataract Surgery","startDateStruct":{"date":"2011-06"},"conditions":["Cataract"],"count":609,"armGroups":[{"label":"T2380","type":"EXPERIMENTAL","interventionNames":["Drug: T2380","Drug: Tetracaine"]},{"label":"Mydriatics and anesthetic","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Mydriatics","Drug: Tetracaine"]}],"interventions":[{"name":"T2380","otherNames":[]},{"name":"Mydriatics","otherNames":["Tropicamide, Phenylpehrine"]},{"name":"Tetracaine","otherNames":["Tetracaine 1%"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Signed and dated informed consent\n* Male or female aged from 40 to 88 years old\n* Scheduled to undergo unilateral cataract surgery\n\nExclusion criteria:\n\n* Combined surgery\n* Previous intraocular surgery","healthyVolunteers":false,"sex":"ALL","minimumAge":"40 Years","maximumAge":"88 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"The Primary Efficacy Variable is Response Based on the Realisation of the Capsulorhexis Without Use of Any Additive Mydriatic Treatment.","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"98.9","spread":null},{"groupId":"OG001","value":"94.7","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":4,"n":295},"commonTop":[]}}}